TRUGOLF, INC. AND DEEP MEDICINE ACQUISITION CORP. CLOSE BUSINESS COMBINATION; TRUGOLF BECOMES PUBLICLY TRADED COMPANY
31 janv. 2024 16h46 HE
|
Deep Medicine Acquisition Corp.
SALT LAKE CITY, Jan. 31, 2024 (GLOBE NEWSWIRE) -- TruGolf, Inc. (Nasdaq: TRUG) ("TruGolf”), among the leading sellers and distributors of golf simulator software and hardware with headquarters in...
TRUGOLF, INC. AND NASDAQ-LISTED SPAC DEEP MEDICINE ACQUISITION CORP. ANNOUNCE FORM S-4 REGISTRATION STATEMENT DECLARED EFFECTIVE BY THE U.S. SECURITIES AND EXCHANGE COMMISSION AND MAILING OF DEFINITIVE PROXY STATEMENT
12 janv. 2024 16h10 HE
|
Deep Medicine Acquisition Corp.
SALT LAKE CITY, Jan. 12, 2024 (GLOBE NEWSWIRE) -- TruGolf, Inc. ("TruGolf”), a leading golf simulator manufacturer and distributor with headquarters in Salt Lake City, Utah, and Deep Medicine...
Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc.
02 août 2023 20h55 HE
|
Deep Medicine Acquisition Corp.
SALT LAKE CITY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- – Deep Medicine Acquisition Corp. (NASDAQ: DMAQ) (“DMAQ” ), a publicly traded special purpose acquisition company, and TruGolf, Inc. ("TruGolf”), a...
Deep Medicine Acquisition Corp. and TruGolf, Inc. Announce the Execution of a Definitive Merger Agreement
31 mars 2023 22h03 HE
|
Deep Medicine Acquisition Corp.
TruGolf, Inc. (“TruGolf”) will become a public company to further advance its software business and increase manufacturing and sales of its golf simulator technology in the United States and...
Deep Medicine Acquisition Corp. Announces Listing Transfer to the Nasdaq Capital Market
16 févr. 2023 16h25 HE
|
Deep Medicine Acquisition Corp.
New York, NY, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) (the “Company”) announced today that it has received approval from the Nasdaq Stock Market (“Nasdaq”)...
Deep Medicine Acquisition Corp. Announces Appointment of a New Director
24 oct. 2022 17h35 HE
|
Deep Medicine Acquisition Corp.
New York, NY, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) (the “Company”) announced today the appointment of Mr. John Chiang as a member to its board of...